Abstract
Hemodialysis vascular access is the “lifeline” for patients on hemodialysis. Unfortunately, because of its poor patency and significant complication rate, it is also the “Achilles heel” of hemodialysis. For example, the current unassisted arteriovenous fistula (AVF) maturation rate is only
Cite
CITATION STYLE
APA
Shenoy, S., Allon, M., Beathard, G., Brouwer-Maier, D., Dember, L. M., Glickman, M., … Wasse, H. (2018). Clinical Trial End Points for Hemodialysis Vascular Access. Clinical Journal of the American Society of Nephrology, 13(3), 490–494. https://doi.org/10.2215/cjn.13321216
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free